Position in ARGX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,516,247
+$684,339 QoQ
Shares Held
3,790
-2.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#168
of 505 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 58%
Shared 0%
None 42%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $119,351,579 across 51 Biotechnology names. ARGX ranks #3 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
106,967 | $53,133,716 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,731 | $24,150,326 | |
| 3 | ARGX |
Argenx SE
This page
|
3,790 | $3,516,247 | |
| 4 | EXEL |
Exelixis, Inc.
|
63,541 | $3,457,265 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
72,286 | $2,660,124 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
10,121 | $2,438,856 | |
| 7 | VCEL |
Vericel Corp
|
51,315 | $2,283,003 | |
| 8 | RPRX |
Royalty Pharma plc
|
29,890 | $1,675,931 |
All Filings in ARGX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,516,247 | 3,790 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $2,831,908 | 3,878 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $3,801,934 | 4,521 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $3,588,228 | 4,865 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,489,308 | 4,516 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $2,552,712 | 4,313 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,634,045 | 4,283 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $2,174,282 | 4,011 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,565,344 | 3,640 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $1,493,772 | 3,794 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,394,275 | 3,665 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $2,168,578 | 4,411 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $823,109 | 2,112 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $555,144 | 1,490 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $504,222 | 1,331 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $408,831 | 1,158 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $247,408 | 653 | Shares | Defined | 2022-07-22 | |
| 2021-03-31 | $619,627 | 2,250 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $616,118 | 2,095 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $533,439 | 2,032 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $454,738 | 2,019 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $242,514 | 1,841 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||